MoneyWorks4Me

Lupin informs about press release

08 Nov 2023 Evaluate

Lupin has informed that it enclosed a Press release regarding launch of Rocuronium Bromide Injection, 50 mg/5 mL (10 mg/mL) and 100 mg/10 mL (10 mg/mL) Multiple-Dose Vials, on receipt of U.S. FDA approval to the Company’s alliance partner Caplin Steriles for its ANDA. 

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1797.70
Dr. Reddys Labs. 1202.70
Cipla 1342.55
Lupin 2018.50
Zydus Lifesciences 1131.00
View more..